NovoCure Limited 0.0% 01-NOV-2025NovoCure Limited 0.0% 01-NOV-2025NovoCure Limited 0.0% 01-NOV-2025

NovoCure Limited 0.0% 01-NOV-2025

No trades
See on Supercharts

Key terms


Outstanding amount
‪560.95 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
0% (Zero)
Coupon frequency
Yield to maturity
5.92%
Maturity date
Nov 1, 2025
Term to maturity
11 months

About NovoCure Limited 0.0% 01-NOV-2025


Sector
Health Technology
Industry
Medical Specialties
Home page
Issue date
Nov 10, 2021
FIGI
BBG00Y28PYF7
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.